SubHero Banner

Food and Drug Administration – Shortage of Vyvanse® (lisdexamfetamine) and generics

September 21, 2023 - Brand Vyvanse (lisdexamfetamine) and generics are in shortage due to increased demand and limited availability of active ingredient due to quotas set by the Drug Enforcement Agency (DEA) for controlled substances. Both capsules and chewable tablets are in short supply.

Download PDF